Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Air Fluidized Therapy Bed Market Outlook (2023 to 2033)

Global air fluidized therapy bed sales are expected to reach US$ 653.5 million in 2023, forecast to grow at a CAGR of 5.7% to be valued at US$ 1,135 million from 2023 to 2033. Air fluidized therapy beds have shown an overall growth of a 4.1% CAGR from 2018 to 2022.

Due to the increasing number of accidents and injuries, it has become an important priority for medical centers to provide comfortable and safe resting areas for their patients, which is why demand for air fluidized therapy beds is growing in the market. The technology used in the beds and their comfort are the factors that help beds thrive in an increasingly competitive market.

A growing need for advanced and cutting-edge healthcare products has contributed to the growth of air fluidized therapy beds worldwide. To treat patients with utmost comfort, hospitals and home care providers are placing significant trust in these beds.

Using air fluidized bed therapy is a beneficial way for those who have wounds, ulcers, and other illnesses, and those who are also suffering from intense pain to be relieved. These beds are also used by patients who are suffering from air fluidized bed therapy. A fluidized air bed therapy is mainly used for the treatment of wounds and other skin-related health conditions. As a result, the players are delivering the beds based on the indications.

To treat the skin, air fluidized beds are specially designed to provide a therapeutic level of moisture and other conditions based on the patient's needs. By reducing the pressure and sharing inside the bed, the airflow inside the bed promotes better sleep for all the body parts. In addition to pressure dynamic and temperature controllers, a variety of sensors are being developed for the comfort of patients.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Which Drivers underpin Air Fluidized Therapy Beds Industry Expansion?

With the growing number of diseases, hospitals must provide better conditions for patients to recover. Air fluidized therapy beds are a great solution for this requirement since they provide suitable air circulation and treatment for patients in medical facilities. As a clinical benefit, AFT reduces the number of hospitalizations and emergency room visits for patients with pressure ulcers who are in long-term care facilities.

In addition, these beds decrease mortality rates among patients who have extensive burns and inhalation injuries and promote rapid healing and greater comfort among patients with burn injuries. As medical centers place utmost emphasis on patient comfort, air fluidized therapy beds are likely to gain great popularity shortly.

They reduce friction, shear, and pressure on the patient, so they get a better chance of recovering faster. Increasing technological innovation and advancement in treatments have made these beds in great demand at hospitals worldwide. Furthermore, for patients with skin-related issues, the demand for less noisy and comfortable beds has helped drive the air fluidized therapy bed market.

AHRQ (Agency for Healthcare Research & Quality) estimates that 2.5 million Americans suffer from pressure ulcers every year. As key companies in the fields prepare battery-operated beds that provide comfort to bedridden patients, the need for comfortable beds has also increased.

Attributes Value
Air Fluidized Therapy Bed Market Size (2023) US$ 653.5 million
Air Fluidized Therapy Bed Market Projected Size (2033) US$ 1,135 million
Air Fluidized Therapy Bed Market CAGR (2023 to 2033) 5.7%

Which Factors are limiting the Growth of the Air Fluidized Therapy Beds Market?

While air fluidized therapy beds have many benefits for medical treatment, there are also a few factors that hinder their growth in the market. It is contraindicated to use air fluidized beds for patients with unstable spines, as the lack of adequate back support causes prolonged coughing for the patient. This impedes the market growth for these beds in the market.

In addition, patients who suffer from pulmonary secretion diseases or have trouble moving should refrain from using these beds to maintain their better health. Although this is not a constraint, in the long run, it limits the growth of air fluidized therapy beds in the market.

For many patients, air fluidized therapy beds are a better solution than conventional round therapy beds, but, due to their special features, the manufacturing costs associated with these beds are very high. Additionally, the maintenance costs are likely to be too high for the hospital as well as the patients which further hinder the growth of these beds in the market. As a result, the cost of air-fluidized therapy beds restricts their future growth in the market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of the Market

Air Fluidized Therapy Bed Market

Attributes Air Fluidized Therapy Bed Market
CAGR (2023 to 2033) 5.7%
Market Value (2033) US$ 1,135 million
Growth Factor Promotes rapid healing
Opportunity Tech-advancements in treatments
Key Trends High demand for battery-operated beds

Compression Therapy Market

Attributes Compression Therapy Market
CAGR (2023 to 2033) 5.4%
Market Value (2033) US$ 4,840 million
Growth Factor Growing incidence of venous ulcers
Opportunity Development of patient-centric products
Key Trends Applications in promoting mental health

Negative Pressure Wound Therapy Market

Attributes Negative Pressure Wound Therapy Market
CAGR (2023 to 2033) 5.2%
Market Value (2033) US$ 6,520 million
Growth Factor Surging prevalence of chronic wounds
Opportunity Growing awareness about advanced wound treatment
Key Trends Rising preference for cost-effective treatment

Regional Analysis

Countries Market Share (2022)
United States 36%
Germany 8.2%
Japan 3.8%

Does North America Hold a Significant Position in the Global Air Fluidized Therapy Beds Market?

North America was the leading market for Air Fluidized Therapy Beds market and the trend is expected to continue into the forecast period owing to the increasing disposable incomes, and growing demand for consumer electronics in the region.

The growing demand for Air Fluidized Therapy Beds for safe packaging purposes due to the increase in online shopping applications is expected to augment the Air Fluidized Therapy Beds market. As per the Future Market Insights analysis, the North American region is forecast to have a 35% total share of the Air Fluidized Therapy Beds market.

North America is expected to be the next dominant region witnessing high adoption rates for the Air Fluidized Therapy Beds market during the forecast period. With a high concentration of manufacturing industries in North America, demand for the Air Fluidized Therapy Beds market is anticipated to rise in the region.

Approximately one-third of the patients in North America have diseases that prevent them from moving, therefore the need for comfortable beds is high in this region. The demand for air fluidized therapy beds in this area is high since these beds are one of the best options available to patients suffering from this condition.

According to this report, air fluidized therapy beds hold a market share of 37.8% by 2022. North American manufacturers typically dominate the global air fluidized bed market without much effort, which helps the region dominate the industry worldwide. Furthermore, the ongoing research and development contribute greatly to the growth of these beds.

Patients are turning towards these beds for home use instead of being hospitalized, resulting in significant growth in the air fluidized therapy bed market. Even though they are expensive, these beds are highly effective and reduce the healing time for pressure injuries such as ulcers, which is why they are so popular in these regions. A variety of research is being conducted to update these beds so that patients with spinal issues also benefit from them.

How Does Growth of the European Air Fluidized Therapy Beds Market unfold?

The use of air fluidized therapy beds in Europe is on the rise due to the increasing awareness regarding the different types of therapies for better recuperation of patients at home in this region. The market share of these beds has grown as more hospitals recommend their use in this region. The market share is expected to reach 28.3% in 2022.

With a growing demand for well-equipped facilities and advanced treatments in homes and hospitals, there is a growing demand for these beds in the market. The growing geriatric population and the presence of chronic diseases in these regions have contributed to the growth of the air fluidized therapy bed market in these regions.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

The Start-up Ecosystem: How Key Players Are Opening Frontiers for Future Growth?

  • Founded in 2020, Bistra Beds is a U.K based Internet-first brand that offers beds for home improvement. The product catalog includes divan beds, storage beds, upholstered beds, etc. It also includes a mattress, head bolder, divan base, etc.
  • Founded in 2018, Elicius is a technology solutions provider for hydrogen fuel cells. Offerings include tubular PEM fuel cell stack(energy storage fuel cell), rapid impedance spectroscopy(for battery management system), and others. Used in powering buildings, cars, trucks, portable electronic devices, and backup power systems.

Competitive Landscape: What are the Leading Players in the Air Fluidized Therapy Beds Market Up to?

  • In December 2021, Baxter acquired Hill-Rom for US$ 15 billion, making it the world's leading Medtech company. As a result, Baxter improved its technologies and supported patients in hospitals and at home more efficiently. Additionally, Baxter anticipates generating a high ROIC through this acquisition.
  • In April 2021, Axens Powering Integrated Solutions announced the sale and purchase agreement for the acquisition of Flowvision, an engineering company specializing in emission abatement systems for the reduction of nitrogen oxides in flue gas from the industry.

Key players

  • Hill-Rom,
  • Dolphin System
  • AURORA MFG,
  • American Medical Equipment
  • Blue Chip Medical
  • Akthel Healthcare BV
  • ArjoHuntleigh

Key Segments

By Indication:

  • Pressure Ulcers
  • Burns
  • Other Indications

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Frequently Asked Questions

What is the growth potential of the air fluidized therapy bed market?

The market has a 5.7% growth potential through 2033.

What is the projected size of the market by 2033?

The global air fluidized therapy bed market size to reach US$ 1,135 million by 2033.

What historical changes did the market undergo?

The global air fluidized therapy bed market advanced at a 4.1% HCAGR from 2018 to 2022.

How big is the air fluidized therapy bed market?

The market is valued at US$ 653.5 million in 2023.

Does North America possess a sizeable share of the global market?

The estimated market share for the North American region is 35%.

How does the European market's growth develop?

From 2023 to 2033, the market share is anticipated to surpass 28.3%.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033

        5.3.1. Pressure Ulcers

        5.3.2. Burns

        5.3.3. Other Indications

    5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Ambulatory Surgical Centers

        6.3.3. Other End Users

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Indication

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Indication

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Indication

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Indication

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Indication

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Indication

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Indication

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Indication

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Indication

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Indication

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Indication

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Indication

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Indication

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Indication

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Indication

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Indication

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Indication

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Indication

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Indication

            15.5.2.2. By End User

    15.6. U.K.

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Indication

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Indication

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Indication

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Indication

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Indication

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Indication

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Indication

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Indication

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Indication

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Indication

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Indication

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Indication

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Indication

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Indication

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Indication

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Indication

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Indication

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Indication

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Indication

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Hill-Rom,

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Dolphin System

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. AURORA MFG,

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. American Medical Equipment

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Blue Chip Medical

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Akthel Healthcare BV

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. ArjoHuntleigh

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Envella

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Kinetic Concepts

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Denghuang Medical

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. Redactron International BV

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. Shandong Hesheng Medical Equipment Co., Ltd.

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Volume (Units) Forecast by Region, 2018 to 2033

Table 3: Global Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 4: Global Volume (Units) Forecast by Indication, 2018 to 2033

Table 5: Global Value (US$ Million) Forecast by End User, 2018 to 2033

Table 6: Global Volume (Units) Forecast by End User, 2018 to 2033

Table 7: North America Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: North America Volume (Units) Forecast by Country, 2018 to 2033

Table 9: North America Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 10: North America Volume (Units) Forecast by Indication, 2018 to 2033

Table 11: North America Value (US$ Million) Forecast by End User, 2018 to 2033

Table 12: North America Volume (Units) Forecast by End User, 2018 to 2033

Table 13: Latin America Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Latin America Volume (Units) Forecast by Country, 2018 to 2033

Table 15: Latin America Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 16: Latin America Volume (Units) Forecast by Indication, 2018 to 2033

Table 17: Latin America Value (US$ Million) Forecast by End User, 2018 to 2033

Table 18: Latin America Volume (Units) Forecast by End User, 2018 to 2033

Table 19: Western Europe Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: Western Europe Volume (Units) Forecast by Country, 2018 to 2033

Table 21: Western Europe Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 22: Western Europe Volume (Units) Forecast by Indication, 2018 to 2033

Table 23: Western Europe Value (US$ Million) Forecast by End User, 2018 to 2033

Table 24: Western Europe Volume (Units) Forecast by End User, 2018 to 2033

Table 25: Eastern Europe Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Eastern Europe Volume (Units) Forecast by Country, 2018 to 2033

Table 27: Eastern Europe Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 28: Eastern Europe Volume (Units) Forecast by Indication, 2018 to 2033

Table 29: Eastern Europe Value (US$ Million) Forecast by End User, 2018 to 2033

Table 30: Eastern Europe Volume (Units) Forecast by End User, 2018 to 2033

Table 31: South Asia and Pacific Value (US$ Million) Forecast by Country, 2018 to 2033

Table 32: South Asia and Pacific Volume (Units) Forecast by Country, 2018 to 2033

Table 33: South Asia and Pacific Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 34: South Asia and Pacific Volume (Units) Forecast by Indication, 2018 to 2033

Table 35: South Asia and Pacific Value (US$ Million) Forecast by End User, 2018 to 2033

Table 36: South Asia and Pacific Volume (Units) Forecast by End User, 2018 to 2033

Table 37: East Asia Value (US$ Million) Forecast by Country, 2018 to 2033

Table 38: East Asia Volume (Units) Forecast by Country, 2018 to 2033

Table 39: East Asia Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 40: East Asia Volume (Units) Forecast by Indication, 2018 to 2033

Table 41: East Asia Value (US$ Million) Forecast by End User, 2018 to 2033

Table 42: East Asia Volume (Units) Forecast by End User, 2018 to 2033

Table 43: Middle East and Africa Value (US$ Million) Forecast by Country, 2018 to 2033

Table 44: Middle East and Africa Volume (Units) Forecast by Country, 2018 to 2033

Table 45: Middle East and Africa Value (US$ Million) Forecast by Indication, 2018 to 2033

Table 46: Middle East and Africa Volume (Units) Forecast by Indication, 2018 to 2033

Table 47: Middle East and Africa Value (US$ Million) Forecast by End User, 2018 to 2033

Table 48: Middle East and Africa Volume (Units) Forecast by End User, 2018 to 2033

List of Charts

Figure 1: Global Value (US$ Million) by Indication, 2023 to 2033

Figure 2: Global Value (US$ Million) by End User, 2023 to 2033

Figure 3: Global Value (US$ Million) by Region, 2023 to 2033

Figure 4: Global Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 5: Global Volume (Units) Analysis by Region, 2018 to 2033

Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 9: Global Volume (Units) Analysis by Indication, 2018 to 2033

Figure 10: Global Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 11: Global Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 12: Global Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 13: Global Volume (Units) Analysis by End User, 2018 to 2033

Figure 14: Global Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 15: Global Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 16: Global Attractiveness by Indication, 2023 to 2033

Figure 17: Global Attractiveness by End User, 2023 to 2033

Figure 18: Global Attractiveness by Region, 2023 to 2033

Figure 19: North America Value (US$ Million) by Indication, 2023 to 2033

Figure 20: North America Value (US$ Million) by End User, 2023 to 2033

Figure 21: North America Value (US$ Million) by Country, 2023 to 2033

Figure 22: North America Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 23: North America Volume (Units) Analysis by Country, 2018 to 2033

Figure 24: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 25: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 26: North America Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 27: North America Volume (Units) Analysis by Indication, 2018 to 2033

Figure 28: North America Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 29: North America Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 30: North America Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 31: North America Volume (Units) Analysis by End User, 2018 to 2033

Figure 32: North America Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 33: North America Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 34: North America Attractiveness by Indication, 2023 to 2033

Figure 35: North America Attractiveness by End User, 2023 to 2033

Figure 36: North America Attractiveness by Country, 2023 to 2033

Figure 37: Latin America Value (US$ Million) by Indication, 2023 to 2033

Figure 38: Latin America Value (US$ Million) by End User, 2023 to 2033

Figure 39: Latin America Value (US$ Million) by Country, 2023 to 2033

Figure 40: Latin America Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 41: Latin America Volume (Units) Analysis by Country, 2018 to 2033

Figure 42: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 43: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 44: Latin America Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 45: Latin America Volume (Units) Analysis by Indication, 2018 to 2033

Figure 46: Latin America Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 47: Latin America Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 48: Latin America Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 49: Latin America Volume (Units) Analysis by End User, 2018 to 2033

Figure 50: Latin America Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 51: Latin America Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 52: Latin America Attractiveness by Indication, 2023 to 2033

Figure 53: Latin America Attractiveness by End User, 2023 to 2033

Figure 54: Latin America Attractiveness by Country, 2023 to 2033

Figure 55: Western Europe Value (US$ Million) by Indication, 2023 to 2033

Figure 56: Western Europe Value (US$ Million) by End User, 2023 to 2033

Figure 57: Western Europe Value (US$ Million) by Country, 2023 to 2033

Figure 58: Western Europe Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 59: Western Europe Volume (Units) Analysis by Country, 2018 to 2033

Figure 60: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 61: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 62: Western Europe Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 63: Western Europe Volume (Units) Analysis by Indication, 2018 to 2033

Figure 64: Western Europe Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 65: Western Europe Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 66: Western Europe Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 67: Western Europe Volume (Units) Analysis by End User, 2018 to 2033

Figure 68: Western Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 69: Western Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 70: Western Europe Attractiveness by Indication, 2023 to 2033

Figure 71: Western Europe Attractiveness by End User, 2023 to 2033

Figure 72: Western Europe Attractiveness by Country, 2023 to 2033

Figure 73: Eastern Europe Value (US$ Million) by Indication, 2023 to 2033

Figure 74: Eastern Europe Value (US$ Million) by End User, 2023 to 2033

Figure 75: Eastern Europe Value (US$ Million) by Country, 2023 to 2033

Figure 76: Eastern Europe Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 77: Eastern Europe Volume (Units) Analysis by Country, 2018 to 2033

Figure 78: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 79: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 80: Eastern Europe Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 81: Eastern Europe Volume (Units) Analysis by Indication, 2018 to 2033

Figure 82: Eastern Europe Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 83: Eastern Europe Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 84: Eastern Europe Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 85: Eastern Europe Volume (Units) Analysis by End User, 2018 to 2033

Figure 86: Eastern Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 87: Eastern Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 88: Eastern Europe Attractiveness by Indication, 2023 to 2033

Figure 89: Eastern Europe Attractiveness by End User, 2023 to 2033

Figure 90: Eastern Europe Attractiveness by Country, 2023 to 2033

Figure 91: South Asia and Pacific Value (US$ Million) by Indication, 2023 to 2033

Figure 92: South Asia and Pacific Value (US$ Million) by End User, 2023 to 2033

Figure 93: South Asia and Pacific Value (US$ Million) by Country, 2023 to 2033

Figure 94: South Asia and Pacific Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 95: South Asia and Pacific Volume (Units) Analysis by Country, 2018 to 2033

Figure 96: South Asia and Pacific Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 97: South Asia and Pacific Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 98: South Asia and Pacific Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 99: South Asia and Pacific Volume (Units) Analysis by Indication, 2018 to 2033

Figure 100: South Asia and Pacific Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 101: South Asia and Pacific Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 102: South Asia and Pacific Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 103: South Asia and Pacific Volume (Units) Analysis by End User, 2018 to 2033

Figure 104: South Asia and Pacific Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 105: South Asia and Pacific Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 106: South Asia and Pacific Attractiveness by Indication, 2023 to 2033

Figure 107: South Asia and Pacific Attractiveness by End User, 2023 to 2033

Figure 108: South Asia and Pacific Attractiveness by Country, 2023 to 2033

Figure 109: East Asia Value (US$ Million) by Indication, 2023 to 2033

Figure 110: East Asia Value (US$ Million) by End User, 2023 to 2033

Figure 111: East Asia Value (US$ Million) by Country, 2023 to 2033

Figure 112: East Asia Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 113: East Asia Volume (Units) Analysis by Country, 2018 to 2033

Figure 114: East Asia Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 115: East Asia Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 116: East Asia Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 117: East Asia Volume (Units) Analysis by Indication, 2018 to 2033

Figure 118: East Asia Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 119: East Asia Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 120: East Asia Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 121: East Asia Volume (Units) Analysis by End User, 2018 to 2033

Figure 122: East Asia Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 123: East Asia Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 124: East Asia Attractiveness by Indication, 2023 to 2033

Figure 125: East Asia Attractiveness by End User, 2023 to 2033

Figure 126: East Asia Attractiveness by Country, 2023 to 2033

Figure 127: Middle East and Africa Value (US$ Million) by Indication, 2023 to 2033

Figure 128: Middle East and Africa Value (US$ Million) by End User, 2023 to 2033

Figure 129: Middle East and Africa Value (US$ Million) by Country, 2023 to 2033

Figure 130: Middle East and Africa Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 131: Middle East and Africa Volume (Units) Analysis by Country, 2018 to 2033

Figure 132: Middle East and Africa Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: Middle East and Africa Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: Middle East and Africa Value (US$ Million) Analysis by Indication, 2018 to 2033

Figure 135: Middle East and Africa Volume (Units) Analysis by Indication, 2018 to 2033

Figure 136: Middle East and Africa Value Share (%) and BPS Analysis by Indication, 2023 to 2033

Figure 137: Middle East and Africa Y-o-Y Growth (%) Projections by Indication, 2023 to 2033

Figure 138: Middle East and Africa Value (US$ Million) Analysis by End User, 2018 to 2033

Figure 139: Middle East and Africa Volume (Units) Analysis by End User, 2018 to 2033

Figure 140: Middle East and Africa Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 141: Middle East and Africa Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 142: Middle East and Africa Attractiveness by Indication, 2023 to 2033

Figure 143: Middle East and Africa Attractiveness by End User, 2023 to 2033

Figure 144: Middle East and Africa Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Medical Bed Market

Published : October 2023

Explore Healthcare Insights

View Reports

Air Fluidized Therapy Beds Market